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A B S T R A C T
Objective: To evaluate whether xenografts derived from hysterectomized patients would implant
successfully and lead to uterine leiomyoma in Wistar rats.
Study design: This experimental study examined six female Wistar rats implanted with uterine
leiomyoma obtained from patients who underwent hysterectomies at the gynecological surgery service
of the HUUFMA. The rats were divided into two groups. Group I consisted of three rats in which the
uterine leiomyoma had been implanted in the parietal peritoneum, and group II consisted of three rats in
which the uterine leiomyoma was implanted in the subcutaneous tissue. The immunosuppressant
mycophenolate mofetil (MMF) was administered orally by gavage (at a dose of 40 mg/kg of body weight)
to prevent transplant rejection starting 15 days before the transplant and continuing throughout the
entire experiment. After four weeks, necrosis and neovascularization were evaluated histologically in
both groups and were classiﬁed as either absent or present. Lymphocytic inﬂammatory inﬁltration was
also examined and classiﬁed as mild, moderate or intense (by hematoxylin and eosin staining), and
ﬁbrosis was classiﬁed as grade I–III (by Masson’s trichrome staining).
Results: Necrosis was absent from all three rats in group I and was observed in only one rat from group II.
Neovascularization was present in two rats from group I and in only one rat from group II. The
lymphocytic inﬂammatory inﬁltrate was mild in two rats and moderate in one rat from group I, and it
was moderate in two rats and intense in one rat from group II. Two rats from group 1 exhibited grade III
ﬁbrosis, and one rat presented grade I ﬁbrosis. In group II, two rats presented grade I ﬁbrosis and one rat
had grade II ﬁbrosis. When necrosis and neovascularization were evaluated as variables, group I
demonstrated greater evidence of successful implantation when compared to group II, indicating that
the peritoneal implantation technique produces better results than the subcutaneous approach
(p = 0.039).
Conclusion: This study demonstrates that the xenotransplantation of uterine leiomyoma into the
parietal peritoneum is more effective than the xenotransplantation of uterine leiomyoma into the
subcutaneous tissue, and it describes a promising new model for the study of leiomyoma in vivo.
 2015 Elsevier Ireland Ltd. All rights reserved.
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Leiomyomas are the most common type of solid pelvic tumor,
and they affect approximately 20–40% of reproductive-age women
[1,2]. Despite this subject being thoroughly studied, the optimal* Corresponding author at: Laborato´rio de Cirurgia Experimental do Maranha˜o,
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0301-2115/ 2015 Elsevier Ireland Ltd. All rights reserved.clinical treatments for this disease remain unknown. Thus, the
development of appropriate experimental models to study
potential new treatment options may be important for improving
treatment options [3–6].
Experimental models of uterine leiomyoma in which patient-
derived xenografts are transplanted into female rats have been
proposed. However, the studies using these models, which range
from simple genetic manipulations to highly complex methods,
have been characterized by problems with reproducibility [7–12].
Preventing transplant rejection is a key step in successful
transplantations that can be achieved with drug therapy, among
W.B. de Sousa et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology 190 (2015) 71–7572other measures. Mycophenolate mofetil (MMF), an inhibitor of
nucleotide synthesis, is among the drugs used to prevent acute
transplant rejection in transplantation surgeries. RS-61443 is a
semi-synthetic morpholinoethyl ester pro-drug that is hydrolyzed
to mycophenolic acid. This drug acts by blocking purine synthesis
[13], thus reducing nucleotide synthesis. Xenotransplantation in
hamsters using immunosuppressive therapy with MMF has been
shown to be satisfactory in studies with cardiac tissue [14] and
porcine islet-like cell clusters [15,16].
Despite all current knowledge that has been obtained regarding
the pathophysiology of uterine leiomyomas, there are no
conservative treatments or drugs that have been proven to be
effective for this condition. Animal models are required to study
potential new therapeutic options. This study sought to develop a
reliable in vivo model of human uterine leiomyoma using Wistar
rats with immunosuppressant mycophenolate mofetil to enable
and contribute to future studies investigating new treatments.
Materials and methods
This pilot experiment used Wistar rats (Rattus norvegicus
albinus) obtained from the animal facility of the Federal University
of Maranha˜o (Universidade Federal do Maranha˜o – UFMA)
implanted with uterine leiomyomas removed from women with
symptoms of leiomyoma who were subjected to hysterectomy at
the Mother and Child Unit of the University Hospital (Hospital
Universita´rio – Unidade Materno Infantil – HUUMI). All surgical
procedures were performed in the surgical center or the
Experimental Surgery Laboratory of Maranha˜o (Laborato´rio de
Cirurgia Experimental do Maranha˜o – LabCEMA) at the HUUMI
between May and July 2014.
This study was performed in accordance with Brazilian law for
the use of experimental animals (Arouca Law No. 11,794/2008) and
the guidelines from the Brazilian College of Animal Experimenta-
tion (Cole´gio Brasileiro de Experimentac¸a˜o Animal – COBEA), an
institution afﬁliated with the International Council for Laboratory
Animal Science. It was approved by the Animal Ethics Committee
(Comiteˆ de E´tica de Uso de Animais – CEUA) of the Federal
University of Maranha˜o and the Research Ethics Committee
(Comiteˆ de E´tica e Pesquisa – CEP) of the University Hospital –
UFMA in agreement with the requirements of Law No. 11,794 from
October 8, 2008.
Six 60-day-old adult virgin female Wistar rats weighing
between 180 and 250 g that presented four or more ﬁve-day
estrous cycles were used in the study. The animals were placed in
polypropylene cages (three rats per cage) with a stainless steel grill
lid that measured 46 cm  31 cm  16 cm. Sawdust was used for
the bedding material, which was changed every 48 h. The animals
were kept under controlled environmental conditions with food
(rat chow, Purina1, Sa˜o Paulo, Brazil) and water available ad
libitum. Noise levels were controlled, the temperature was
maintained at 22 8C  2 8C, the relative humidity was kept between
40 and 60% and a 12:12 light–dark cycle was utilized starting seven
days prior to the start of experiments to allow for acclimation.
The immunosuppressant mycophenolate mofetil (Cellcept1
500 mg) was administered by oral gavage (at a dose of 40 mg/kg
body weight) starting 15 days before the xenotransplantation
procedure and continuing throughout the entire experiment to
prevent transplant rejection [15,17].
Uterine tumors were obtained from patients undergoing a
hysterectomy at the HUUMI due to symptoms of multiple uterine
leiomyomas. The patients were recruited from the general
gynecology outpatient clinic based on indications for surgical
treatment that were observed during the standard preoperative
routine provided by HUUMI. Patients diagnosed with infectious
diseases, such as HIV, syphilis, hepatitis B and hepatitis C wereexcluded from the study. After the patients were selected and
informed about the study, they signed an informed consent form
accepting their inclusion in the study.
Abdominal hysterectomy was performed under anesthesia.
There was no discrimination regarding the location (submucosal,
intramural or subserosal) of the ﬁbroids. Subsequently, tumors
measuring 3–5 mm in diameter were selected, avoiding the need
of unnecessary trauma to the myoma so that it could be
transplanted whole. The remaining tumors and excess material
was sent along with the uterus for histopathological assessment
using routine pathology protocols. After the removal and
conﬁrmation of the uterine leiomyoma, the sample identiﬁed
with the patient’s name was placed in normal saline solution and
transported to the Experimental Surgery Laboratory of Maranha˜o
(LabCEMA) for the xenotransplantation. At this time, the recipient
rat was also identiﬁed. The interval between the end of the
hysterectomy and the beginning of the xenotransplantation
procedure was approximately 15–30 min.
All rats were subjected to a 12-h fasting period and weighed
using an electronic scale with the values (in grams) recorded in the
protocol. After weighing, the rats were anesthetized with a mixture
of 2% xylazine and 5% ketamine at a ratio of 1:1 (0.2 ml for each
100 g body weight). The anesthetics were administered intramus-
cularly into the posterior border of the left thigh.
In group I, which consisted of three animals, the xenograft was
surgically transplanted into the peritoneal cavity via the abdomen.
This surgical technique involved a 3-cm midline incision that was
made in the caudal third of the abdomen and cutting the skin,
muscular aponeurotic plane and peritoneum, followed by the
identiﬁcation of the organs of the abdominal cavity. In this group, a
piece of uterine leiomyoma was transplanted into the right side of the
peritoneal cavity in the middle third of the incision (0.5 cm laterally)
and was attached with a single stitch using 5–0 nylon sutures (Fig. 1A).
Group II also consisted of three animals, but the xenografts were
transplanted subcutaneously for this group (Fig. 1B). For these
transplant surgeries, a small 3-cm incision was made in the rat’s
skin in the caudal third of the right ﬂank of the rat. Once the incision
was made, the skin layer (upwards of 1.5 cm) was separated from
the aponeurosis. Then, a piece of uterine leiomyoma was
transplanted into the subcutaneous tissue of the rat.
After xenotransplantation, the animals were monitored daily
for four weeks and maintained under constant environmental
conditions. They were provided rat chow, the immunosuppressive
therapy described above and estrogen supplementation with
estradiol valerate (Prymogina 1 mg1). For the estrogen supple-
mentation, one pill was macerated and diluted in 250 ml of water,
which was available ad libitum and changed every 24 h.
After the procedure, the rats were euthanized via sodium
thiopental administration (Tiopental1) and evaluated. Euthanasia
was performed according to resolution No. 714 from June 20,
2002 of the Brazilian Federal Council of Veterinary Medicine. Death
was characterized by respiratory arrest and the complete absence
of reﬂexes [18].
After the conﬁrmation of death, all animals were subjected to
surgical approaches using the same initial incision, and the
xenograft was assessed in both groups.
The tissues removed were rinsed with 0.9% sodium chloride and
kept in a labeled container with 10% buffered formalin. Tissues
were sent to the Anatomic Pathology Division of the University
Hospital (UFMA) and embedding in a parafﬁn block, staining with
Hematoxylin and Eosin (H&E) and Masson’s trichrome staining.
Finally, all tissues were subjected to histological evaluations using
light microscopy by a pathologist.
Subsequently, slides from each group were examined by the
pathology service and evaluated according to the following histologi-
cal criteria: cell necrosis, neovascularization and lymphocytic
Fig. 1. (A) (group I) Implantation human uterine leiomyoma tissue into the peritoneal cavity via the abdomen (arrow); (B) (group II) the xenografts were transplanted
subcutaneous (arrow). (C) Macroscopic aspect of a human uterine leiomyoma xenograft (arrow) in the parietal peritoneum (group I); (D) Macroscopic aspect of a human
uterine leiomyoma xenograft (arrow) in subcutaneous tissue (group II). Both C and D images were taken four weeks after the transplant of human uterine leiomyoma in
female Wistar rats that were immunosuppressed with mycophenolate mofetil (40 mg/kg) and supplemented with estrogen (estradiol valerate) during the entire experiment.
Table 1
Histological variables of human uterine leiomyoma xenografts four weeks after
being transplanted into the parietal peritoneum (Group I) and subcutaneous tissue
(Group II) of female Wistar rats immunosuppressed with mycophenolate mofetil
(40 mg/kg) and supplemented with estrogen (estradiol valerate) throughout the
entire experiment.
Variable Group I Group II p-value
Lymphocytic inﬂammatory inﬁltrate
Mild 2 (66.7) 0 (0.0) 0.400
Moderate 1 (33.3) 2 (66.7)
Intense 0 (0.0) 1 (33.3)
Neovascularization
Present 2 (66.7) 1 (33.3) 1.000
Absent 1 (33.3) 2 (66.7)
Fibrosis grade
Grade 1 0 (0.0) 2 (66.7) 0.600
Grade 2 1 (33.3) 1 (33.3)
Grade 3 2 (66.7) 0 (0.0)
Necrosis
Present 0 (0.0) 2 (66.7) 0.400
Absent 3 (100.0) 1 (33.3)
Total 3 (50.0) 3 (50.0)
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(by Masson’s trichrome staining).
The presence or absence of necrosis was evaluated, and necrosis
was only considered to be absent if it was observed in 0% of the
cells on a given slide [19,20].
The analyses of neovascularization were assessed by the
presence or absence of small tortuous vessels in the ﬁbrin-
leukocyte buffer [21].
Collagen and smooth muscle tissue (uterine ﬁbroid) content
was assessed using Masson’s trichrome staining, and the presence
of ﬁbrosis was classiﬁed on a scale from I to III according to the
staining intensity. The following criteria were used to measure
ﬁbrosis: grade I less than 33%, grade II between 34 and 66% and
grade III between 67 and 100% [22].
The presence of lymphocytic inﬂammatory inﬁltration was
classiﬁed as mild (<30%), moderate (31–60%) or intense (61–100%).
If the histopathological analysis revealed that the uterine
leiomyoma was not benign, the donor patient would be informed
about the test results to exclude the risk of malignancy.
Data were expressed as frequencies (absolute and relative) for
the categorical variables shown in the tables and ﬁgures. Fisher’s
exact test was applied to correlate the categorical variables with
the experimental group. Stata1 software (version 12) was used
for the analysis. Regarding the statistical interpretations of the
results, the signiﬁcance threshold was set at an alpha value of less
than 0.05 for all tests.
Results
At the end of the experiment, all six rats were euthanized, three
from group I and three from group II. During the experimental
period (four weeks), no complications with the oral gavage,
anesthesia or surgery were observed, nor were any postoperativecomplications, such as infections. The uterine ﬁbroids that were
xenotransplanted into the rats maintained the macroscopic
characteristics of ﬁbroid tissue in both groups (Fig. 1C and D).
Based on the histological evaluations by H&E staining, necrosis
was absent in all three rats in group I, but it was absent in only one
rat in Group II. Neovascularization was observed in two rats in
group I but only one rat in group II. The degree of lymphocytic
inﬂammatory inﬁltration was mild in two rats and moderate in one
rat in group I, while it was moderate in two rats and intense in one
rat in group II (Table 1).
Fig. 2. Photomicrograph of a human leiomyoma xenograft in the peritoneum of a
female Wistar rat (Group I) showing neovascularization (arrows) and the absence of
cellular atypia after 14 days of immunosuppressant administration [mycophenolate
mofetil (40 mg/kg)] and estrogen supplementation (estradiol valerate).
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demonstrated that two rats presented grade III ﬁbrosis and one rat
presented grade I ﬁbrosis in group I. In group II, two rats had grade I
ﬁbrosis, and one had grade II ﬁbrosis (Table 1).
The H&E analysis revealed the presence of small vessels around
the xenografts, which indicates the neovascularization of the
transplanted leiomyoma. Cellular atypia and mitosis were not
identiﬁed in any of the samples (Fig. 2).
When the histological variables necrosis and neovasculariza-
tion were considered together, a statistically signiﬁcant difference
between the groups was observed, with group I showing evidence
of greater implant success compared to group II, p = 0.039 (Fig. 3).
Comments
The scientiﬁc community has been intensifying its search for
improved experimental models, and several new models have
been proposed since the Eker rat model was ﬁrst reported. In the
Eker model, tumors develop in response to a germline mutation in
the tuberous sclerosis 2 (TSC2) gene, and this tumor predisposition
is inherited in an autosomal dominant pattern [8,23]. However,
since this animal model was ﬁrst reported, newer studies have
proposed establishing alternative in vivo models.
Hassan et al. described gene therapy in animals implanted
subcutaneously with uterine leiomyoma xenografts. In the HassanFig. 3. Association between the examined variables (neovascularization and necrosis)
in the human uterine leiomyoma xenograft four weeks after transplantation into the
parietal peritoneum (Group I) or subcutaneous tissue (Group II) of female Wistar rats
immunosuppressed with mycophenolate mofetil (40 mg/kg) and supplemented with
estrogen (estradiol valerate) throughout the entire experiment.study, adenovirus administration was required to maintain the
grafted leiomyoma in NOG I mice, a genetically selected strain of
mice. Tumor vascularization was maintained in these animals by
the overexpression of pro-angiogenic factors [9].
Suo et al. proposed an experimental model of leiomyoma that
was used for the ﬁrst imaging analysis of a leiomyoma implant and
the development of uterine ﬁbroids. The authors compared two
different ﬂuorescence imaging techniques. The Suo model involved
the use of immune-compromised mice, gene therapy of uterine
leiomyomas, exogenous estrogen supplementation and veriﬁcation
using diagnostic imaging. Although this model, which used gene
therapy and a sophisticated technological apparatus, proved to be
reproducible, its high cost limits its widespread use [24].
Ishikawa et al. used an abdominal approach to study
leiomyoma in rats. Leiomyoma cells were grafted under the renal
capsule of immunodeﬁcient NOD/SCID/IL-2R gamma null (NSG)
mice. The implant location under the renal capsule is well
vascularized, a fact that facilitates the implantation process.
Despite satisfactory results, the limiting factors of the model
include the risks associated with this technique. In addition, an
expensive genetically selected strain of mouse is required [25].
Due to the limiting factors of their previous study, Ishikawa
et al. subsequently reported using a mouse strain that was less
immunodeﬁcient than the NSG, NOD/SCID, BALB/c and NOD/SCID
mice [25]. These authors reported advantages such as better graft
implants and lower costs. In their second study, mice were
ovariectomized and supplemented with intramuscular estrogen.
The effectiveness of the implant was evaluated by measuring the
activity of the estrogen receptor using immunohistochemistry. The
primary limitation of this newer model is the fact that successfully
targeting the implantation site requires good surgical skills.
Tsujji et al. transplanted human uterine leiomyoma xenografts
subcutaneously in an immunodeﬁcient mouse strain (NOD/SCID/g
c-null: NOG) and reported several practical advantages in the
technique itself and in the approach of leiomyomas, which led to
lower risk levels associated with the implantation technique for
these animals. However, as described above, this model requires
technology to produce a genetically selected strain of immunode-
ﬁcient mice, which makes it more difﬁcult to implement and
reproduce [10].
In the present study, the histological variables of necrosis and
tissue neovascularization demonstrated that human uterine
leiomyoma xenografts transplanted into rats via a peritoneal
route of administration are superior to those delivered via a
subcutaneous route. Wistar rats and the histopathological
evaluation techniques used in this experiment are relatively
inexpensive and are accessible for our community. Regarding
immunosuppression, a non-genetic model was proposed that
features a low cost and accessible oral supplementation. Myco-
phenolate mofetil (MMF) was chosen as the immunosuppressive
agent because it has been readily available in Brazil since 1996. In
addition, its properties are known and its effects on the induction
and maintenance of xenografts have been well documented, thus
reducing the risk of acute rejection [17].
In the majority of the studies addressing experimental
leiomyomas [8,9] estrogen has been administered either subcuta-
neously or intramuscularly. Because our group did not have access
to injectable estrogen, oral supplementation was used. For this
supplementation method, estrogen was diluted in the water that
was consumed daily by the rats. Speciﬁcally, 1 mg of estradiol
valerate was diluted in 250 ml of water once daily and provided for
the rats to drink. The daily consumption of water was observed to
be approximately 10–20 ml/day, which is consistent with the
water-consumption levels reported in the literature. The daily
intake of estradiol valerate per rat was estimated to be
approximately 0.04–0.08 mg/day.
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leiomyomas, that the peritoneal approach is more appropriate and
describes a simpliﬁed protocol for studying experimental leio-
myomas in Wistar rats immunosuppressed with mycophenolate
mofetil. This study may contribute to the development of new
therapeutic strategies for uterine leiomyoma.
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